Main Menu

What’s New?

Connect With Us


Read Carefully

Cardiovascular Disease is currently the leading cause of death in India and its prevalence is projected to rise. In addition to an aging population, the skyrocketing incidence of hypertension, Obesity and Diabetes all contribute to the staggering prevalence of about 4.6 million patients with heart failure in India. 30% of these patients die in hospital. 20% of hospital admissions is due to heart failure with a 44% readmission within 6 months of discharge. Heart failure patients have an extremely high mortality of 50% in 5 years. Mitral regurgitation is a major component, worsening outcomes in these patients. Now a revolutionary new devise, a tiny clip called MitraClip has been proven to drastically improve outcomes in these patients.

On the 35th year of service in heart care, the Apollo Hospitals Group, is privileged to announce that it is among a select few centers in India and the only center in Chennai accredited to perform the MitraClip procedure for these heart failure patients. Data has shown that benefit from this therapy is directly dependent on the skill and expertise of the operators performing the treatment and hence the stringent quality control and limited centers. Dr. Mathew Samuel, Director Interventional Cardiology & Dr. Sai Satish, Senior Interventional Cardiologist, Apollo Hospitals Chennai, will be initiating this therapy on the first few patients in the country mid-November this year.

Apollo Hospitals, Asia’s largest and most trusted multi-specialty chain of hospitals also recently announced the launch of its Comprehensive Training Centre for Trans Catheter Aortic Valve Implantation (TAVI) in the City. The centre was inaugurated by Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group. The prevalence of aortic stenosis increases sharply with age after the sixth decade and is expected to have a significant impact on the geriatric health care system of India, given the rapid increase in life expectancy in recent years. Severe Aortic Stenosis, once diagnosed has an astounding mortality of 90% in 4 years. Though TAVI has been around in the west for more than a decade, it has only been adopted in India since late 2015. Even now very few centres can perform this life saving procedure mainly due to lack of training. This specialized training centre is designed to provide benchmark training to cardiologists from across the country, in an aim to benefit as many patients as possible. Dr. Peter Andreka, General Director, chief of Adult Cardiology,  Gottsegen Gyorgy, Hungarian institute of Cardiology, he has implanted over a 1000 valves and is here with today. Dr. Andreka and his team will be instrumental in helping us structure this program.

Announcing the launch of the Trans Catheter valve training institute, Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group, Said, “The need of the hour is to have a robust scientific approach to identify the challenges in India in dealing with the patients affected with cardiac disease. This training centre would be an ideal platform to discuss, debate, and educate doctors in diagnosis and treatment of heart conditions with newer therapies.”

“Together we all are here working to strengthen India’s healthcare system to reach national and international goals, Apollo Hospitals has always been supportive in bringing world-class treatment options to India. This training institute will be a step towards culminating a permanent solution to the increasing cardiovascular Diseases in our country.”


It was in 1983, that Dr. Prathap Reddy made a pioneering endeavour by launching India’s first corporate hospital – Apollo Hospitals in Chennai. Over the years Apollo Hospitals has established itself as home to the largest cardiac practice in India with over 160,000 cardiac surgeries. Apollo Hospitals is also the world’s largest private cancer care provider and runs the world’s leading solid organ transplant program.

As Asia’s largest and most trusted healthcare group, its presence includes 9,215 beds across 64 Hospitals, 2,500 Pharmacies, over 90 Primary Care and Diagnostic Clinics, 110  plus Telemedicine Centres and 80 plus Apollo Munich Insurance branches spanning   the length and breadth of the Country. As an integrated healthcare service provider with Health Insurance services, Global Projects Consultancy capability, over 15 medical education centres and a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research Apollo Hospitals has been at the forefront of new medical breakthroughs with the most recent investment being that of commissioning the first Proton Therapy Center across Asia, Africa and Australia in Chennai, India. Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of International standards within the reach of every individual.

In a rare honour, the Government of India issued a commemorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For more than 30 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.

Leave a reply

Your email address will not be published. Required fields are marked *



Recieve daily updates from the near-future.

By signing up, you agree to our Privacy Policy

ta_INTamil en_USEnglish